Impact of the COVID-19 Pandemic on the Mental Health and Quality of Life of Patients with Psoriasis in Tertiary Care; A One-year Follow-up

Authors

  • Georgia Lada The Dermatopharmacology Unit, University of Manchester, 1st Floor, Barnes Building, Salford Royal Hospital, Stott Lane, Salford M6 8HD, UK; Division of Neuroscience and Experimental Psychology, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK
  • Hector Chinoy National Institute for Health Research Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, The University of Manchester, Manchester, UK
  • Peter S. Talbot Division of Neuroscience and Experimental Psychology, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK;Greater Manchester Mental Health NHS Foundation Trust, Manchester, UK
  • Richard B. Warren Dermatology Centre, Salford Royal NHS Foundation Trust, National Institute for Health Research Manchester Biomedical Research Centre, The University of Manchester, Manchester M6 8HD, UK
  • C. Elise Kleyn Dermatology Centre, Salford Royal NHS Foundation Trust, National Institute for Health Research Manchester Biomedical Research Centre, The University of Manchester, Manchester M6 8HD, UK

DOI:

https://doi.org/10.2340/actadv.v102.2464

Keywords:

psoriasis, Covid 19, depression, quality of life

Abstract

Abstract is missing (Short communication)

Downloads

Download data is not yet available.

References

Lada G, Chinoy H, Heal C, Warren RB, Talbot PS, Kleyn CE. Depression and suicidality in patients with psoriasis and the role of psoriatic arthritis; a cross-sectional study in a tertiary setting. J Acad Consult Liaison Psychiatry 2022; 63: 372-383.

https://doi.org/10.1016/j.jaclp.2021.12.007 DOI: https://doi.org/10.1016/j.jaclp.2021.12.007

Mahil SK, Yates M, Yiu Z, Langan SM, Tsakok T, Dand N, et al. Describing the burden of the COVID-19 pandemic in people with psoriasis: findings from a global cross-sectional study. J Eur Acad Dermatol Venereol 2021; 35: e636-e640.

https://doi.org/10.1111/jdv.17450 DOI: https://doi.org/10.1111/jdv.17450

Dowlatshahi EA, Wakkee M, Arends LR, Nijsten T. The prevalence and odds of depressive symptoms and clinical depression in psoriasis patients: a systematic review and meta-analysis. J Invest Dermatol 2014; 134: 1542-1551.

https://doi.org/10.1038/jid.2013.508 DOI: https://doi.org/10.1038/jid.2013.508

Rush AJ, Trivedi MH, Ibrahim HM, Carmody TJ, Arnow B, Klein DN, et al. The 16-item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry 2003; 54: 573-583.

https://doi.org/10.1016/S0006-3223(02)01866-8 DOI: https://doi.org/10.1016/S0006-3223(02)01866-8

Finlay AY, Khan G. Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210-216.

https://doi.org/10.1111/j.1365-2230.1994.tb01167.x DOI: https://doi.org/10.1111/j.1365-2230.1994.tb01167.x

Sheehan DV, Giddens JM, Sheehan IS. Status Update on the Sheehan-Suicidality Tracking Scale (S-STS) 2014. Innov Clin Neurosci 2014; 11: 93.

Weiss DS. The impact of event scale: revised. Cross-cultural assessment of psychological trauma and PTSD: Springer; 2007: p. 219-238.

https://doi.org/10.1007/978-0-387-70990-1_10 DOI: https://doi.org/10.1007/978-0-387-70990-1_10

Fancourt D, Steptoe A, Bu F. Trajectories of anxiety and depressive symptoms during enforced isolation due to COVID-19 in England: a longitudinal observational study. Lancet Psychiatry 2021; 8: 141-149.

https://doi.org/10.1016/S2215-0366(20)30482-X DOI: https://doi.org/10.1016/S2215-0366(20)30482-X

Sloan M, Gordon C, Lever E, Harwood R, Bosley MA, Pilling M, et al. COVID-19 and shielding: experiences of UK patients with lupus and related diseases. Rheumatol Adv Pract 2021; 5: rkab003.

https://doi.org/10.1093/rap/rkab003 DOI: https://doi.org/10.1093/rap/rkab003

Pierce M, McManus S, Hope H, Hotopf M, Ford T, Hatch SL, et al. Mental health responses to the COVID-19 pandemic: a latent class trajectory analysis using longitudinal UK data. Lancet Psychiatry 2021; 8: 610-619.

https://doi.org/10.1016/S2215-0366(21)00151-6 DOI: https://doi.org/10.1016/S2215-0366(21)00151-6

Lamb R, Matcham F, Turner M, Rayner L, Simpson A, Hotopf M, et al. Screening for anxiety and depression in people with psoriasis: a cross-sectional study in a tertiary referral setting. Br J Dermatol 2017; 176: 1028-1034.

https://doi.org/10.1111/bjd.14833 DOI: https://doi.org/10.1111/bjd.14833

Tribó MJ, Turroja M, Castaño-Vinyals G, Bulbena A, Ros Cucurull E, García-Martínez P. Patients with moderate to severe psoriasis associate with higher risk of depression and anxiety symptoms: results of a multivariate study of 300 Spanish individuals with psoriasis. Acta Derm Venereol 2019; 99: 417-422.

https://doi.org/10.2340/00015555-3114 DOI: https://doi.org/10.2340/00015555-3114

Lada G, Chinoy H, Talbot PS, Warren RB, Kleyn CE. The effect of the Covid-19 pandemic on illness perceptions of psoriasis and the role of depression: findings from a cross-sectional study. Skin Health Dis 2022; 2: e145.

https://doi.org/10.1002/ski2.145 DOI: https://doi.org/10.1002/ski2.145

Zhao N, Li W, Zhang S-F, Yang BX, Sha S, Cheung T, et al. Network analysis of depressive symptoms among residents of Wuhan in the later stage of the COVID-19 pandemic. Front Psychiatr 2021; 12: 735973.

https://doi.org/10.3389/fpsyt.2021.735973 DOI: https://doi.org/10.3389/fpsyt.2021.735973

John A, Eyles E, Webb RT, Okolie C, Schmidt L, Arensman E, et al. The impact of the COVID-19 pandemic on self-harm and suicidal behaviour: update of living systematic review. F1000Research 2021; 9: 1097.

https://doi.org/10.12688/f1000research.25522.2 DOI: https://doi.org/10.12688/f1000research.25522.2

Downloads

Additional Files

Published

2022-11-14

How to Cite

Lada, G., Chinoy, H., Talbot, P. S., Warren, R. . B., & Kleyn, C. E. (2022). Impact of the COVID-19 Pandemic on the Mental Health and Quality of Life of Patients with Psoriasis in Tertiary Care; A One-year Follow-up. Acta Dermato-Venereologica, 102, adv00814. https://doi.org/10.2340/actadv.v102.2464